Camcevi האיחוד האירופי - איסלנדית - EMA (European Medicines Agency)

camcevi

accord healthcare s.l.u. - leuprorelin mesilate - blöðruhálskirtli - innkirtla meðferð - camcevi is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy.

Scemblix האיחוד האירופי - איסלנדית - EMA (European Medicines Agency)

scemblix

novartis europharm limited - asciminib hydrochloride - kyrningahvítblæði, mergbreytilegt, langvinnt, bcr-abl jákvætt - Æxlishemjandi lyf - scemblix is indicated for the treatment of adult patients with philadelphia chromosome positive chronic myeloid leukaemia in chronic phase (ph+ cml cp) previously treated with two or more tyrosine kinase inhibitors (see section 5.

Eligard Stungulyfsstofn og leysir, lausn 7,5 mg איסלנד - איסלנדית - LYFJASTOFNUN (Icelandic Medicines Agency)

eligard stungulyfsstofn og leysir, lausn 7,5 mg

recordati industria chimica e farmaceutica s.p.a.* - leuprorelinum acetat - stungulyfsstofn og leysir, lausn - 7,5 mg

Eligard Stungulyfsstofn og leysir, lausn 45 mg איסלנד - איסלנדית - LYFJASTOFNUN (Icelandic Medicines Agency)

eligard stungulyfsstofn og leysir, lausn 45 mg

recordati industria chimica e farmaceutica s.p.a.* - leuprorelinum acetat - stungulyfsstofn og leysir, lausn - 45 mg

Eligard Stungulyfsstofn og leysir, lausn 22,5 mg איסלנד - איסלנדית - LYFJASTOFNUN (Icelandic Medicines Agency)

eligard stungulyfsstofn og leysir, lausn 22,5 mg

recordati industria chimica e farmaceutica s.p.a.* - leuprorelinum acetat - stungulyfsstofn og leysir, lausn - 22,5 mg